Intra-Cellular Therapies Inc (ITCI)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

$126.50

Buy

$128.00

arrow-up$0.28 (+0.22%)

Prices updated at 24 Jan 2025, 22:29 EST
| Prices minimum 15 mins delay
|
Prices in USD
Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.
NASDAQ
arrow-down-0.5%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$127.61 - $127.19
$128.00 - $62.78
-
13,530.14m
-
-
4,073,483
11.82
1,091,346.45
0.71
96.38m
US46116X1019
-0.87
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.